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BACKGROUND: To establish proof of principle of a link between phenotypic expression and stiffness after 
TKR.   
METHODS: From 100 patients, genetic expression of markers of fibrosis were performed for 15 synovial 
samples from patients categorised as ‘best post-operative range of movement (ROM)’ and 15 samples from 
patients with ‘worst ROM’. These markers included Matrix Metalloproteinases (MMPs), A Disintegrin and 
Metalloproteinases with Thrombospondin (ADAMTs) and Tissue Inhibitors of Matrix Metalloproteinases 
(TIMPs). Genetic marker data were compared to Oxford Knee Scores (OKS) and Pain Catastrophizing Scores 
(PCS). 
RESULTS: Quantitative markers for gene expression demonstrated more outliers in stiff compared to non-stiff 
knees, suggesting a greater imbalance in pro- and anti-fibrotic markers in stiff knees.  Whilst there was a 
significant difference in the range of post-operative knee flexion (p=0.001) and extension (p=0.001), there was no 
statistically significant difference between stiff and non-stiff knees in pre-operative or post-operative OKS 
(p≥0.06). There was no difference in the individual components of the individual PCS score items nor the PCS 
total scores when stiff and non-stiff knees were compared (p>0.05). 
CONCLUSION: Biological factors, namely gene expression of MMPs, TIMPs and ADAMTs, may contribute 
towards post-TKR stiffness. This now warrants further investigation to better understand this relationship based 
on larger, multi-centre, cohorts. 
LEVEL OF EVIDENCE: Level 3. 









Knee stiffness after Total Knee Replacement (TKR) is not uncommon and can be debilitating [1-3]. Whilst a 
functional range of motion (ROM) has been defined as 67° of flexion during the swing phase of gait [4], a range 
less than 90° of flexion can impair stair ascent and rising from a seated position [5]. Patient expectation is now 
that a minimum of 90° of flexion is achieved post-operatively, and preferably more [6]. Stiffness is just one of 
several, possibly interlinked, reasons why patients are dissatisfied after TKR [7,8].  
Factors associated with stiff (and painful) TKRs include component mal-sizing and mal-orientation and poor soft-
tissue balancing [9]. However, there are patients who are stiff who do not have an implant or other technical issue. 
Patient factors such as genetic makeup and pain perception have been implicated as possible causes for knee 
stiffness post-TKA, but neither factor has been firmly established [10,11].  
Disentangling the aetiology of significant post-operative pain and/or stiffness after TKR is difficult [1,2,]. Surgical 
factors, psychosocial factors, genetic factors and central (nervous system) factors may all play a role [13]. From 
a genetic perspective, there are a number of key genetic markers of fibrosis which may be associated with stiffness 
post-TKA. Matrix Metalloproteinases (MMPs) have traditionally been thought to degrade extracellular matrix 
and therefore excessive fibrosis was thought to correlate with a lack of MMP production. However, this may be 
too simplistic an approach and that wound healing and scar formation are a complex interaction between pro- and 
anti-fibrotic mechanisms and that MMPs can be both pro- and antifibrotic [1,4]. A Disintegrin and 
Metalloprotease (ADAM) and A Disintegrin and Metalloprotease with Thrombospondin Motif (ADAMTS) are 
active proteases with physiological function similar to MMPs. Tissue Inhibitors of Matrix Metallo Proteinases 
(TIMPS) are functionally reciprocal to MMPs. An imbalance between MMPs and TIMPS expression would lead 
to a pro-fibrotic state if the activity of TIMPs was favoured over that of MMPs.   
Given this uncertainty in the TKR population, the purpose of this study was to establish proof of principle as to 
whether there is a link between phenotypic expression and stiffness after TKR and patient-reported pain and 
disability scores. This is important as determining people at risk of stiffness post-TKA based on genetic markers 






MATERIALS AND METHODS 
 
We collected data on 150 consecutive patients who underwent primary TKR at an NHS university hospital. We 
included only those patients who had a primary TKR for tibio-femoral arthritis and who had a cruciate retaining 
Genesis II (Smith and Nephew®, Memphis USA) TKR. Any patient with an inflammatory arthropathy or primary 
patello-femoral arthritis was excluded in addition to those who required an additional procedure during TKR such 
as a lateral release, bone grafting or implant augment. We also excluded any patient who needed a significant 
further distal femoral resection of greater than 2mm (additional to the standard primary distal femoral cut) or who 
required a polyethylene insert of greater than 15mm. Valgus knees were not excluded unless this was severe 
enough to warrant a posterior stabilized implant.  
All patients followed a standard post-operative recovery programme including early mobilisation day 1 post-
operatively and post-operative physiotherapy and occupational therapy prior to discharge. All patients were 
discharged with a home exercise plan and reviewed by their surgical team at six weeks post-operatively.  
Tissue Sample and Gene Expression Analysis 
Synovial tissue for gene expression analysis was collected intra-operatively from the supra-patella pouch. This 
tissue was chosen as it is routinely sacrificed to accurately measure the size of the femoral component, and fibrosis 
in the supra-patella pouch is known to be associated with post-operative adhesions and stiffness post-TKR [10,14]. 
This tissue was immediately placed after collection into a solution of RNAlater at 4°C for 24 hours and 
subsequently frozen at -80°C until the tissue was required for analysis.  
Samples from 100 patients were obtained. For all patients who donated samples, knee flexion (mean: 105.6) and 
and extension ROM (mean: -2 ) was measured both pre-operatively and at six-weeks post-operatively. Based on 
this, 15 patients were catagorised into a ‘best ROM post-operatively’ subgroup and 15 in a ‘worst ROM post-
operatively’ subgroup, representing the highest or lowest values from within the cohort respectively. This sample 
size was determined based on previous recommendations of required proof of principle sample size [10]. The 
ROM for these subgroups are presented in Table 1 and Table 2. The samples for these individuals underwent gene 
expression testing and analysed using reverse transcription and qRT-PCR. In this process, RNA was extracted 
using the ultraturax followed by the tri-spin RNA extraction protocol [15]. Tissue was immersed in trizol (1ml 
per 100mg of tissue) and homogenised using the ultraturax (2 x 10 second blasts). 125 µg/ml glycogen was added 
and incubated at room temperature for three minutes. 2/5 sample volume of chloroform was added to the samples 
which were shaken vigorously for 15 seconds then incubated at room temperature for five minutes. After 
centrifugation (at 12000 x g for 15 minutes) the upper phase was transferred into a fresh 1.5ml tube. An equal 
volume of isopropanol was added, and samples were incubated at room temperature for at least 10 minutes. 
Samples were centrifuged for 10 minute at 12000 x g and the supernatant was discarded. Pellets were washed 
with 1ml ethanol (vortexed then centrifuged for five minutes at 7500 x g before the ethanol was removed), air 
dried and re-suspended in 50µl of analytical grade water.  
RNA was reverse transcribed into a cDNA library using the superscript II kit from Invitrogen®(Carlsbad, CA. 
USA) as per the manufacturer’s instructions. RNA was primed with random hexamers and reverse transcribed 
with the superscript II kit according to manufacturer’s instructions. In brief, RNA was incubated at 70oC for 10 
minutes with 200ng random hexamers. 4µl 5x sample buffer, 10mM DTT, 0.125mM dNTP’s (2.5mM), 200units 
Superscript II and 40units RNase inhibitor were added and incubated for one hour at 42oC and at 70 oC for 10 
minutes. To determine whether the reverse transcription had worked effectively, standard Taqman©(Thermo 
Fisher Scientific, MA, USA) analysis of the housekeeping gene was performed on a sample of the cDNA.  
The standard qRT-PCR programme was run using the Applied biosystems 7500 real time PCR system. Each 
reaction was performed in a volume of 25μl including; 10ng cDNA, 33% KAPA Probe fast qPCR kit Mastermix 
(2x), 0.2 nM each of the forward and reverse primer and 0.1 nM of probe. The thermal cycles were as follows: 
50°C for two minutes, 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds and 60°C for one minute. 
Following this, Taqman low density array was performed on the samples. 500ng of cDNA was loaded onto each 
port of custom designed 48 gene/port TLDA array card and run according to manufacturer’s instructions using 
the Applied biosystems 7900HT Real-Time PCR System and Applied biosystems Sequence Detection Systems 
(SDS 2.3 and RQ manager 1.2) software (Thermo Fisher Scientific). The thermal cycles were as follows: 50°C 
for two minutes, 94.5°C for 10 minutes followed by 40 cycles of 97°C for 30 seconds and 59.7°C for one minute. 
Data were normalised to the most stable housekeeping gene, beta actin, and expressed as 2^- Delta Ct.  
The following broad groups of genes were tested: Extracellular matrix metalloproteinases (ADAMTS), Matrix 
metalloproteinases (MMPs) and inhibitors of MMPs (TIMPS). A full list of the genes tested is shown in 
Supplementary Table 1. 
 
Clinical Assessment 
We collected pre-operative and six-week post-operative Oxford Knee Scores (OKS) [16] and Pain Catastrophizing 
Scale scores (PCS) [17]. The Oxford Knee Score is a 12-item, participant-completed questionnaire which has 
demonstrated reliability and validity for the assessment of knee disability for the TKR population [17]. The PCS 
is a 13-item participant completed questionnaire which is reliable and valid for the assessment of perceived pain 
experience in people with chronic pain [19]. It comprises of three sub-sections (rumination, magnification, 
helplessness) to form a total score. We also collected pre-operative and six-week post-operative knee flexion and 
extension ROM measured by a single researcher (AB) following a standardised procedure using a goniometer 
[20]. This was performed with the participant sat at the edge of the examination couch and asked to actively flex 
their knee as far as possible. The bony landmarks of the lateral malleolus and the greater trochanter of the hip 
were identified and the axis of the goniometer was place on the lateral aspect of the knee joint line.  
We defined knee stiffness as either a failure to achieve 90° of flexion and/or a total ROM of less than 90° at six 
weeks post-operatively.  
The six week post-operative x-rays of those patients who were tested for genetic expression were examined by a 
consultant knee surgeon (IM) to exclude surgical causes of stiffness. Post-operative plain x-ray films were 
examined using the institute’s Picture Archiving and Communication System (PACS), for alignment, over or 
under-sizing, and overstuffing of the patellofemoral joint. The examiner was blinded as to whether the patient was 
stiff or not.  
 
Data Analysis 
Descriptive statistics were used (mean and standard deviation) to assess the difference in genetic expression 
(ADAMTS, MMPs, TIMPs) between 15 participants who presented with post-operative stiff knee, and the 15 
participants who did not have a stiff knee. Given that this is a proof of principle study with only 30 participants, 
inferential statistical tests were not performed to assess genetic expression. However within-group pre- versus 
post-operative differences for OKS and PCS were assessed using the non-parametric tests the Wilcoxin Matched 
Pairs Test, whilst the Mann—Whitney Test was used to assess the within-group pre- versus post-operative 
differences for OKS and PCS. Statistical significant was denoted as p<0.05. All statistical analyses were 





The characteristics of the 30 participants who underwent gene expression analysis is presented in Table 1. As this 
illustrates, there were no statistically or clinically significant differences between the groups in respect to 
characteristics with the exception of a greater proportion of the stiff knee cohort being female compared to the 
non-stiff knee cohort (86.7% vs. 53.3%).  
 
Gene Expression Analysis 
Figure 1 illustrates a trend for an overall difference between the stiff and non-stiff knees for fibrotic characteristics. 
These are confirmed by the individual gene analysis (Figure 2; Figure 3; Figure 4) indicating a trend for a 
difference in gene expression findings between the two cohorts. There was greater variance in gene expression in 
the stiff group. There was consistently a higher mean value for MMPs, TIMPs and ADAMTS for the stiff group 
compared to non-stiff group (Figure 2; Figure 3; Figure 4).  
 
X-ray Analysis 
There were no significant differences in component alignment, size or overstuffing between the two groups. There 
was one set of x-rays missing for one patient who was in the non-stiff  group. There were two patients whose 




The results for analysis comparing pre-operative and post-operative outcomes between the stiff and non-stiff knee 
groups are presented in Table 1 and Table 2. There was no clinically or statistically significant difference between 
the stiff knee and non-stiff knee groups for pre-operative total OKS (mean: 17.7 vs. 15.8; p=0.31) or post-operative 
score (mean: 23.5 vs. 21.5; p=0.06). There was no significant difference between the change in OKS pre- to post-
operatively between the stiff and non-stiff knee groups (mean: 7.2 vs. 13.7; p=0.14). 
There was no clinically or statistically significant difference for total PCS score (mean: 18.6 vs. 19.0; p=0.94). 
Similarly, there was no difference between the stiff knee and non-stiff knee group post-operatively for the specific 
sub-domains of the PCS (Rumination, Magnification and Helplessness) (p≥0.28; Table 2).  
Whilst there was no statistically significant difference in pre-operative range of knee extension or flexion (p≥0.31; 
Table 1), post-operatively there was a difference in both knee extension ROM (mean: -10.1 vs. 2.1; p=0.001) and 




The findings of this study suggest that biological factors may be associated with knee stiffness. There are higher 
mean value for MMPs, TIMPs and ADAMTS in stiff knees compared to non-stiff knees. However, based on this 
cohort, there is limited evidence of a relationship between knee stiffness and PCS. The results are based on a small 
number of cases. Further study is warranted to explore whether this trend in finding remains true when tested with 
a larger, multi-centre, cohort.  
There is a subtle balance between enzyme activity which is essential for wound healing and that which may 
promote excessive fibrosis which may be associated with post-operative joint stiffness [21]. MMP activity is 
essential during the proliferative phase of wound healing as the wound is ‘rebuilt’. MMP is also necessary for the 
remodelling or maturation phase [22]. This is a desirable effect as far as surgical incision wound healing by 
primary intention is concerned, but is deleterious as far as wound healing by secondary intention is concerned as 
there is a large raw area of exposed tissue when a TKR is performed [21]. The myofibroblastic activity reaches a 
peak at around 15 days and is much reduced by 30 days after the wound was created [21]. Thus the balance 
between MMP activity and TIMP activity is crucial [21,22]. Our results concur with this suggesting that ADAMTs 
and MMP activity is not significantly counteracted by TIMP in the stiff knee patients. 
Our study did not demonstrate a significant difference in PCS scores between the stiff and non-stiff group, even 
when the individual subsections contributing to the total score were analysed. This may be attributed to the small 
number of patients analysed, thereby being influenced or the tool being insensitive to detect a change in this 
population. Other tools may be more appropriate, such as those which assess global pain and psychological 
distress, such as fibromyalgia scoring systems [22] compared to the PCS score. Whilst neither tool is designed to 
distinguish between individuals who may do more poorly because of pain compared to stiffness. However, our 
results would indicate that stiffness is a significant factor in a functionally poor TKR and should therefore be 
considered an important but separate domain to evaluate in this subgroup of the TKR population.  
This study presented with two principal limitations. First, although radiological assessment was undertaken to 
assess mal-rotation through plain x-ray, this may have been more accurately assessed through Computed Axial 
Tomography scanning. This was not performed as it was considered unethical to subject the a normal ROM 
participant to excessive radiation. Second, although the number of participants was small, it was regarded that this 
sample size was acceptable to assess proof of principle for genetic expression and knee stiffness [10]. There were 
no previous papers looking at fibrosis in TKR to estimate a power calculation on. The authors accept that the 
paper does not provide a definitive answer to a complex problem, but would conclude that further investigation 




Joint stiffness is a multifactorial problem after TKR but biological factors may play a significant role in stiffness 
after TKR. The interplay between biological factors and central factors (such as pain perception) may be important 
but their relationship remains unclear, warranting further investigation. Future definitive investigation would 
improve understanding on the phenotype of patients who experience stiffness post-TKR, to improve stratified pre- 
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FIGURE AND TABLE LEGENDS 
 
Figure 1. Volcano plot comparing best versus worst knee range of movement.  
Figure 2. MMP gene expression in synovial samples divided into worst and best ROM. Data was normalised to 
β actin and expressed as relative quantification (RQ) 2^-ΔCt. Mean values are indicated by the black lines. 
Figure 3. TIMP  gene expression in synovial samples divided into worst and best ROM. Data was normalised to 
β actin and expressed as relative quantification (RQ) 2^-ΔCt. Mean values are indicated by the black lines. 
Figure 4. ADAM and ADAMTS gene expression in synovial samples divided into worst and best ROM. Data 
was normalised to β actin and expressed as relative quantification (RQ) 2^-ΔCt. Mean values are indicated by 
the black lines. 
 
Table 1: Demographic characteristics for the stiff and non-stiff knee groups. 
Table 2: Post-operative comparisons for Oxford Knee Score and PCS score for the stiff and non-stiff knee 
groups. 
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Figure 2: Matrix metalloproteinases (MMP) gene expression in synovial samples divided into ‘worst’ and ‘best’ 
range of motion.  
 
 
MMP – matrix metalloproteinases; RQ (2^-ΔCt) – relative quantification of 2^- Delta Ct  
*mean values represented by the black line 
 
Figure 3: TIMP  gene expression in synovial samples divided into ‘worst’ and ‘best’ range of motion.  
 
 
RQ (2^-ΔCt) – relative quantification of 2^- Delta Ct; TIMPS - Tissue Inhibitors of Matrix Metallo Proteinases 
*mean values represented by the black line 
 
 
Figure 4. ADAM and ADAMTS gene expression in synovial samples divided into ‘worst’ and ‘best’ range of 
motion. 
 
ADAM - A Disintegrin and Metalloprotease; ADAMTS - A Disintegrin and Metalloprotease with Thrombospondin 
Motif ; RQ (2^-ΔCt) – relative quantification of 2^- Delta Ct;  
*mean values represented by the black line 
Table 1: Demographic characteristics for the stiff and non-stiff knee groups. 
 Stiff Knee Group Non-Stiff Knee Group Difference (p-value; 
95% CI) 
N 15 15  
Mean age (SD) 64.93 (8.40) 68.47 (9.56) 0.291 (-10.26 to 3.20) 
Gender (m/f) 2/13 7/8 0.919 (not estimateable) 
Mean pre-operative extension (SD) -6.47 (6.16) -3.87 (4.98) 0.214 (-6.79 to 1.59) 
Mean pre-operative flexion (SD) 95.00 (9.78) 95.53 (15.97) 0.913 (-9.37 to 10.44) 
Mean pre-operative OKS (SD)  17.73 (5.48) 15.80 (7.88) 0.307 (-2.46 to 7.52) 




Table 2: Post-operative comparisons for Oxford Knee Score and PCS score for the stiff and non-stiff knee 
groups. 
 Stiff Knee Group Non-Stiff Knee Group Difference  
(p-value; 95% CI) 
N 15 15  
Mean post-operative extension (SD) -10.07 (7.33) -2.07 (2.37) 0.001 (3.92 to 12.08) 
Mean post-operative flexion (SD) 78.00 (13.34) 105.67 (6.78) 0.001 (-35.57 to -19.75) 
Mean post-operative OKS (SD) 23.46 (8.62) 21.47 (7.18) 0.06 (-10.72 to 0.19) 
Mean post-operative PCS (Total Score) (SD) 18.60 (10.52) 19.00 (16.60) 0.938 (-9.99 to 10.79) 
Mean post-operative PCS (Rumination) (SD) 6.73 (5.27) 6.33 (6.00) 0.848 (-4.62 to 3.82) 
Mean post-operative PCS (Magnification) (SD) 2.87 (1.41) 4.00 (3.68) 0.275 (-0.95 to 3.22) 
Mean post-operative PCS (Helplessness) (SD) 9.00 (5.32) 8.73 (7.57) 0.912 (-5.16 to 4.63) 
CI: confidence interval; f – female; m – male; PCS - Pain Catastrophizing Scale Score; OKS – Oxford Knee 
Score; SD – standard deviation 
 
  
Supplementary Table 1: Full list of genes tested 
ADAMTS MMPS TIMPS 
ADAM12-Hs01106101_m1 MMP1-Hs00899658_m1 TIMP1-Hs00171558_m1 
ADAMTS1-Hs00199608_m1 MMP10-Hs00233987_m1 TIMP2-Hs00234278_m1 
ADAMTS10-Hs00372835_m1 MMP11-Hs00171829_m1 TIMP3-Hs00165949_m1 
ADAMTS12-Hs00229594_m1 MMP12-Hs00899662_m1 TIMP4-Hs00162784_m1 
ADAMTS13-Hs00260148_m1 MMP13-Hs00233992_m1  
ADAMTS14-Hs00365506_m1 MMP14-Hs00237119_m1  
ADAMTS15-Hs00373520_m1 MMP15-Hs00233997_m1  
ADAMTS16-Hs00373526_m1 MMP16-Hs01095537_m1  
ADAMTS17-Hs00330236_m1 MMP17-Hs00211754_m1  
ADAMTS18-Hs00373501_m1 MMP19-Hs00275699_m1  
ADAMTS19-Hs00999225_m1 MMP2-Hs00234422_m1  
ADAMTS2-Hs00247973_m1 MMP21-Hs00377680_m1  
ADAMTS3-Hs00610744_m1 MMP23A;MMP23B-Hs00270380_m1  
ADAMTS4-Hs00192708_m1 MMP24-Hs00198580_m1  
ADAMTS5-Hs00199841_m1 MMP25-Hs01554789_m1  
ADAMTS6-Hs01058097_m1 MMP26-Hs00983740_m1  
ADAMTS7-Hs00276223_m1 MMP27-Hs00223193_m1  
ADAMTS8-Hs00199836_m1 MMP28-Hs01020031_m1  
ADAMTS9-Hs00172025_m1 MMP3-Hs00968308_m1  
 MMP7-Hs01042795_m1  
 MMP8-Hs01029057_m1  
 MMP9-Hs00957562_m1  
 
 
 
 
 
 
